As of 3:59pm ET
| +0.77 / +6.14%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 17.00, with a high estimate of 23.00 and a low estimate of 10.00. The median estimate represents a +27.63% increase from the last price of 13.32.
The current consensus among 4 polled investment analysts is to Hold stock in NewLink Genetics Corp. This rating has held steady since September, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.